Product Details
Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate 50/300/300 mg Tablets**
Dolutegravir (Dolutegravir Sodium); Lamivudine; Tenofovir Disoproxil Fumarate50 mg; 300 mg; 300 mg
Tablet
ROA
Oral
Applicant Name
Oxus Pharma Ltd
NRN
C4-1704
Status
Active
Composition
Dolutegravir (sodium)/Lamivudine/Tenofovir disoproxil fumarate 50 mg/300 mg/300 mg Tablets. Each film coated tablet contains: Dolutegravir Sodium equivalent to Dolutegravir 50 mg, Lamivudine USP 300 mg, Tenofovir Disoproxil Fumarate 300 mg equivalent to 245 mg of Tenofovir Disoproxil
ATC Code
J05AR27
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 x 30's;1 x 90's (in HDPE bottles)
Product Description
Film coated Tablets
Manufacturer Name
Macleods Pharmaceuticals Ltd.
Manufacturer Country
INDIA
Approval Date
2024-10-31
Expiry Date
2029-10-30